Publication
2026
- Mundy, R. M. et al. 2026. Identification of a novel fiber shaft structural motif and overexpression of key transcripts elucidated in human adenovirus D 10. PLoS Pathogens 22 (4) e1014182. (10.1371/journal.ppat.1014182)
2025
- Lovatt, C. et al. 2025. Investigating endothelial cell transduction and hexon: platelet factor 4 binding of ChAdOx1 in the context of vaccine-induced thrombotic thrombocytopenia. Journal of Thrombosis and Haemostasis 23 (10), pp.3319-3326. (10.1016/j.jtha.2025.06.006)
- Mundy, R. 2025. Structural and biological insights into novel adenovirus-based platforms for therapeutic applications. PhD Thesis , Cardiff University.
2023
- Mundy, R. M. et al. 2023. Broad sialic acid usage amongst species D human adenovirus. npj Viruses 1 1. (10.1038/s44298-023-00001-5)
2022
- Bates, E. A. et al. 2022. Development of a low seroprevalence, αvβ6 integrin selective virotherapy based on human adenovirus type 10. Molecular Therapy - Oncolytics 25 , pp.43-56. (10.1016/j.omto.2022.03.007)
2021
- Baker, A. T. et al. 2021. The fiber knob protein of human adenovirus type 49 mediates highly efficient and promiscuous infection of cancer cell lines using a novel cell entry mechanism. Journal of Virology 95 (4) e01849-20. (10.1128/JVI.01849-20)
2019
- Baker, A. et al. 2019. Human adenovirus type 26 uses sialic acid - bearing glycans as a primary cell entry receptor. Science Advances 5 (9) eaax3567. (10.1126/sciadv.aax3567)
- Baker, A. T. et al. 2019. Adenovirus serotype 26 utilises sialic acid bearing glycans as a primary cell entry receptor. bioRxiv (10.1101/580076)
Articles
- Mundy, R. M. et al. 2026. Identification of a novel fiber shaft structural motif and overexpression of key transcripts elucidated in human adenovirus D 10. PLoS Pathogens 22 (4) e1014182. (10.1371/journal.ppat.1014182)
- Lovatt, C. et al. 2025. Investigating endothelial cell transduction and hexon: platelet factor 4 binding of ChAdOx1 in the context of vaccine-induced thrombotic thrombocytopenia. Journal of Thrombosis and Haemostasis 23 (10), pp.3319-3326. (10.1016/j.jtha.2025.06.006)
- Mundy, R. M. et al. 2023. Broad sialic acid usage amongst species D human adenovirus. npj Viruses 1 1. (10.1038/s44298-023-00001-5)
- Bates, E. A. et al. 2022. Development of a low seroprevalence, αvβ6 integrin selective virotherapy based on human adenovirus type 10. Molecular Therapy - Oncolytics 25 , pp.43-56. (10.1016/j.omto.2022.03.007)
- Baker, A. T. et al. 2021. The fiber knob protein of human adenovirus type 49 mediates highly efficient and promiscuous infection of cancer cell lines using a novel cell entry mechanism. Journal of Virology 95 (4) e01849-20. (10.1128/JVI.01849-20)
- Baker, A. et al. 2019. Human adenovirus type 26 uses sialic acid - bearing glycans as a primary cell entry receptor. Science Advances 5 (9) eaax3567. (10.1126/sciadv.aax3567)
- Baker, A. T. et al. 2019. Adenovirus serotype 26 utilises sialic acid bearing glycans as a primary cell entry receptor. bioRxiv (10.1101/580076)
Thesis
- Mundy, R. 2025. Structural and biological insights into novel adenovirus-based platforms for therapeutic applications. PhD Thesis , Cardiff University.